4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Clover Biopharmaceuticals, Ltd. (2197) operates in the Biotechnology industry and is headquartered in Shanghai, China with about 257 employees. Its market capitalization is roughly CNY 3 billion. In the fiscal year ended 2025-12-31, 2197 reported CNY 4M in revenue and (CNY 205M) in net income.
Clover Biopharmaceuticals, Ltd., a biotechnology company, engages in the research and development, manufacture, and commercialization of vaccines in Mainland China and internationally.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 4M | CNY 38M | CNY 39M | CNY 0M | — |
| Gross Profit | CNY 3M | CNY 22M | CNY 24M | CNY 0M | — |
| Operating Income (EBIT) | (CNY 217M) | (CNY 242M) | (CNY 872M) | (CNY 1.9B) | — |
| Net Income | (CNY 205M) | (CNY 903M) | (CNY 138M) | (CNY 2.5B) | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | — | — | — | — | (CNY 101M) |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 458M | CNY 813M | CNY 2.1B | CNY 4.7B | — |
| Total Liabilities | CNY 2.3B | CNY 2.4B | CNY 2.8B | CNY 5.4B | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2197 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms